Want to join the conversation?
During 3Q15, the collaboration with $AGTC became effective and $BIIB made an upfront payment of $124MM, which included a $30MM equity investment in $AGTC, prepaid R&D expenditures of $58.4MM and total licensing and other fees of $35.6MM. $AGTC is eligible to receive milestone payments aggregating in excess of $1Bil under the collaboration.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?